Hang Su
Impact in
- Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Catalysis top 2%
- Catalysis and Oxidation Reactions
- Ammonia Synthesis and Nitrogen Reduction
Papers in
-
- Retinoids in leukemia and cellular processes 4
-
- Iron-based superconductors research 10
- Co-authors
- Xu Teng (6 shared papers)Yunfei Yuan (3 shared papers)Shi‐Mei Zhuang (3 shared papers)Jian‐Rong Yang (2 shared papers)Zhiming Liu (4 shared papers)Li Xu (1 shared paper)Jun Huang (1 shared paper)Junhua Li (2 shared papers)
- Journals
- Physical review. B. (7 papers)International Journal of Biological Macromolecules (2 papers)Oncotarget (2 papers)Biochemical and Biophysical Research Communications (2 papers)Translational Lung Cancer Research (2 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Hang Su
69 papers receiving 2.8k citations
Hang Su's Hit Papers
Peers
Comparison fields: 5 of 140
- Cancer Research 859
- Catalysis 387
- Molecular Biology 1.1k
- Materials Chemistry 572
- Process Chemistry and Technology 33
Countries citing papers authored by Hang Su
This map shows the geographic impact of Hang Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hang Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hang Su more than expected).
Fields of papers citing papers by Hang Su
This network shows the impact of papers produced by Hang Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hang Su. The network helps show where Hang Su may publish in the future.
Co-authors
The 25 scholars most cited alongside Hang Su, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 76 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | MicroRNA-101, Down-regulated in Hepatocellular Carcinoma, Promotes Apoptosis and Suppresses Tumorigenicity Hit paper breakdown → | 2009 | 534 |
| 2 | 2008 | 298 | |
| 3 | 2016 | 225 | |
| 4 | 2020 | 198 | |
| 5 | 2013 | 154 | |
| 6 | 2015 | 139 | |
| 7 | 2014 | 106 | |
| 8 | 2017 | 89 | |
| 9 | 2016 | 83 | |
| 10 | 2015 | 81 | |
| 11 | 2014 | 80 | |
| 12 | 2018 | 59 | |
| 13 | 2017 | 50 | |
| 14 | 2023 | 40 | |
| 15 | 1993 | 38 | |
| 16 | 2008 | 36 | |
| 17 | 2015 | 34 | |
| 18 | 2011 | 34 | |
| 19 | 2024 | 33 | |
| 20 | 2022 | 28 |
About Hang Su
Hang Su is a scholar working on Molecular Biology, Electronic, Optical and Magnetic Materials, Cancer Research, Condensed Matter Physics and Oncology, having authored 76 papers that have together received 2.8k indexed citations. Recurring topics across this work include Iron-based superconductors research (10 papers), Rare-earth and actinide compounds (10 papers), Catalytic Processes in Materials Science (5 papers), Cancer-related Molecular Pathways (5 papers), Catalysis and Oxidation Reactions (5 papers), Retinoids in leukemia and cellular processes (4 papers), Physics of Superconductivity and Magnetism (4 papers) and Cancer, Hypoxia, and Metabolism (4 papers). The work is most often cited by research in Cancer Research (859 citations), Catalysis (387 citations), Molecular Biology (1.1k citations), Materials Chemistry (572 citations) and Process Chemistry and Technology (33 citations). Hang Su has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Xu Teng, Yunfei Yuan, Shi‐Mei Zhuang, Jian‐Rong Yang, Zhiming Liu, Li Xu, Jun Huang, Junhua Li, Yuan Li and Biaohua Chen. Their work appears in journals such as Physical review. B., International Journal of Biological Macromolecules, Oncotarget, Biochemical and Biophysical Research Communications and Translational Lung Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.